News

An anti-Zionist group claimed responsibility for the overnight vandalism at the State House gate Wednesday that drew a swarm ...
The post California Is Advancing a Bill To Punish Social Media Companies for Not Suppressing Speech appeared first on ...
AstraZeneca's gefurulimab showed clinical benefits and favorable safety in Phase 3 trial for adults with anti-AChR ...
The outspoken co-founder of Return to the Land, a relatively new whites-only group based in northern Arkansas, said the group ...
An investigation found that Kairos house had said the “presence of ‘Zionists’ in the group was making residents of the house ...
We’re not asking for them to change their businesses,” said Jonathan Greenblatt, CEO and national director of the ADL. “We’re just asking for them to get it right.”The post Gottheimer, ...
AstraZeneca has bagged a win for its rare disease pipeline, with its Phase III trial of gefurulimab demonstrating the drug’s ...
We must do all we can to combat anti-Jewish acts and speech. We must speak out against antisemitism whenever and wherever we ...
Gefurulimab is a dual-binding nanobody designed to bind to the C5 protein in the terminal complement cascade and prevent the overactivation of the body’s immune system.
High school English teacher Ashlie Crosson, NEA’s 2025 National “Teacher of the Year,” set the tone by claiming that the ...
Social media users believed that the Department of Homeland Security published a tweet referencing a white supremacist slogan ...
AstraZeneca announced on Thursday that its investigational treatment ‘gefurulimab’ achieved statistically significant and ...